Möchten Sie immer auf dem neuesten Stand bleiben?

Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.

Beim Leserkonto Anmelden Leserkonto Erstellen

03. Juni 2025 09:40 ET | Quelle: SNS Insider pvt ltd

Gabapentin Market Size to Hit USD 3.55 Billion by 2032, Driven by Rising Cases of Epilepsy, Neuropathic Pain, and Off-Label Use – SNS Insider

Austin, June 03, 2025 (GLOBE NEWSWIRE) -- According to SNS Insider, the global Gabapentin market was USD 2.33 billion in 2023, is projected to reach USD 3.55 billion by 2032, expanding at a compound...
16. Oktober 2023 11:14 ET | Quelle: Acumen Research and Consulting

Gabapentin Market revenue is expected to increase by USD 4.1 Billion by 2032, with a 5.7% CAGR from 2023 to 2032

LOS ANGELES, Oct. 16, 2023 (GLOBE NEWSWIRE) -- The Gabapentin Market Size accounted for USD 2.4 Billion in 2022 and is projected to achieve a market size of USD 4.1 Billion by 2032 growing at a CAGR...
24. März 2022 06:55 ET | Quelle: Industry Research

Global Gabapentin Market [2022-2027] | COVID-19 Impact with Top Manufacturers Analysis (Novartis, TEVA, Mylan, Pfizer, etc) | Industry Size-Share, Demand-Supply Scenario, Emerging Trends, Production, Opportunities and Challenges

Pune, March 24, 2022 (GLOBE NEWSWIRE) -- "Final Report will add the analysis of the impact of COVID-19 on this industry." Global “Gabapentin Market” Research Report 2022-2027 is a historical...